Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma

Figure 1

Study design summary: Phase I study of an autologous vaccine manufactured in plants by magnICON technology for the treatment of patients with relapsed or transformed follicular lymphoma.